Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals

Fig. 2

SCD1 inhibits Gefitinib-induced cytotoxicity in lung cancer. a, b The cell vitality of A549 and H1573 cells with or without SCD1 overexpression was assessed by CCK-8 assay after treatment with Gefitinib (20 μM) and A939572 (1 nM) for 48 h. Meanwhile, the total apoptosis of A549 (c) and H1573 cells (d) was also determined by flow cytometry. *p < 0.05, **p < 0.01, data is presented as mean ± sd

Back to article page